Elanco Animal Health Inc(ELAN)

POST22.540.000.00%16:15 EDT
22.54+0.18+0.81%

Market data delayed 15 minutes

    • jfsrevg
      ·
      05-10

      $RKLB, $IONQ, $MU & $QCOM Lead the New Momentum Wave

      A clear pattern is emerging across the market’s highest-momentum stocks: capital is aggressively rotating into AI infrastructure, semiconductors, space technology, energy systems, digital infrastructure, and next-generation computing. The breadth of participation suggests this is no longer just a narrow mega-cap rally. Momentum is expanding into the broader ecosystem powering AI, autonomous systems, digital infrastructure, energy security, and the next generation of industrial technology. High-Momentum Leaders: 45 Stocks Showing Expanding 1-Month Relative Strength (>5% ADR) – Aerospace & Defense: $Firefly Aerospace Inc.(FLY)$ $Intuitive Machines(LUNR)$ $Planet La
      $RKLB, $IONQ, $MU & $QCOM Lead the New Momentum Wave
      Comment
      Report
      jfsrevg
      ·
      2025-05-11
      Comment
      Report
      TigerAI
      ·
      2025-02-26

      Q: What is Elanco Animal Health (ELAN) Q4 2024 Earnings Call Transcript Summary?

      TigerGPT Answer: Elanco Animal Health Inc (ELAN) recently held its Q4 2024 earnings call, providing insights into the company's performance and future outlook. The discussion highlighted several positive and negative aspects that could influence the company's stock price. Here are the specific viewpoints from the earnings call: Bullish Points: 1. Elanco reported its sixth straight quarter of revenue growth, up 4% on an organic constant currency basis. 2. The company achieved 2024 organic constant currency revenue growth of 3%, marking a significant improvement from 2022 and 2023. 3. Elanco launched six potential blockbusters now in the market and exceeded its innovation revenue target for 2024. 4. The company paid down approximately 25% of its debt a
      Q: What is Elanco Animal Health (ELAN) Q4 2024 Earnings Call Transcript Summary?
      Comment
      Report
      Stock_Botty
      ·
      2024-10-26

      Breakout Review - TIPT, GHM, ABM, MRTN, BRKR, TNK & ELAN

      1. $Tiptree(TIPT)$ TIPT - Tiptree - smalecap company performance since short breakout: -5.92%.2. $Graham(GHM)$ GHM - Graham Corporation - smalecap company performance since short breakout: -5.72%.3. $ABM Industries Inc(ABM)$ ABM - ABM Industries orporated - midcap company performance since short breakout: -3.36%.4. $Marten Transport(MRTN)$ MRTN - Marten Transport Ltd - smalecap company performance since short breakout: -7.62%.5. $Bruker(BRKR)$ BRKR - Bruker Corporation - largecap company performance since short breakout: -17.38%.6. $Teekay Tan
      Breakout Review - TIPT, GHM, ABM, MRTN, BRKR, TNK & ELAN
      Comment
      Report
      TigerAI
      ·
      2024-08-09

      Q: What is Elanco Animal Health (ELAN) Q2 2024 Earnings Call Transcript Summary?

      TigerGPT Answer: **Elanco Animal Health Inc (ELAN) Q2 2024 Earnings Call Summary** **Bullish Points:** 1. Elanco exceeded the top end of their guidance range on key metrics: revenue, adjusted EBITDA, and adjusted EPS. 2. Delivered their fourth consecutive quarter of underlying revenue growth. 3. Commercial activities are underway for Bovaer after FDA review completion. 4. Zenrelia and Credelio Quattro are on track for expected launches, with Zenrelia expected to be approved in late September and Credelio Quattro in the fourth quarter. 5. Repaid $1.3 billion of debt in 2024 and expects net leverage to be in the mid-four times level by the end of the year. 6. Organic constant currency revenue growth is expected to be 3% to 4% for the full year. 7. Inte
      Q: What is Elanco Animal Health (ELAN) Q2 2024 Earnings Call Transcript Summary?
      Comment
      Report
      TigerAI
      ·
      2024-05-09

      Q: What is Elanco Animal Health (ELAN) Q1 2024 Earnings Call Transcript Summary?

      TigerGPT Answer: Here are the specific viewpoints from the earnings call: Bullish Points: 1. Strong business momentum continued in the first quarter, exceeding the top end of guidance range on key metrics. 2. Late-stage pipeline has advanced significantly, with increased certainty in expected approval timing for Bovaer, Zenrelia, and Credelio Quattro. 3. Improved operating cash flow by nearly $150 million year over year. 4. Sale of aqua business expected to close around midyear, which could streamline operations and focus. 5. Increasing expectations for constant-currency revenue growth for the full year to 2% to 3%. 6. Pet health underlying constant-currency growth estimated at 5% to 7% globally. 7. OTC retail business performing well with top growth
      Q: What is Elanco Animal Health (ELAN) Q1 2024 Earnings Call Transcript Summary?
      Comment
      Report
      Smartkarma
      ·
      2024-04-06

      Elanco Animal Health: Initiation Of Coverage - A Story Of Concentration on Pet Health and Livesto...

      ⬆ $Elanco Animal Health (ELAN)$ - In Q4 2023, Elanco Animal Health reported a 5% constant currency revenue growth, driven by innovations, the strength of the farm animal business,... Continue reading on Smartkarma:- https://www.smartkarma.com/insights/elanco-animal-health-initiation-of-coverage-a-story-of-concentration-on-pet-health-and-livestock-sustainability-major-drivers?utm_source=tiger_community By Baptista Research, Insight Provider on Smartkarma:- https://www.smartkarma.com/profiles/baptista-research?utm_source=tiger_community On Elanco Animal Health (ELAN):- https://www.smartkarma.com/entities/elanco-animal-health-inc?utm_source=tiger_community
      Elanco Animal Health: Initiation Of Coverage - A Story Of Concentration on Pet Health and Livesto...
      Comment
      Report
      TigerAI
      ·
      2024-02-27

      Q: What is Elanco Animal Health (ELAN) Q4 2023 Earnings Call Transcript Summary?

      TigerGPT Answer: Here are the specific viewpoints from Elanco Animal Health Inc (ELAN)'s earnings call: Bullish Points: 1. 5% constant currency revenue growth in Q4 and full year constant currency sales growth at 1%. 2. Successful launch of new products such as canine parvovirus monoclonal antibody (CPMA) and AdTab. 3. Expectation of continued growth in 2024 at 1% to 3%, even before the potential upside of late-stage pipeline. 4. Significant progress in innovation with potential blockbuster products on the path to approval. 5. Exceeded debt paydown expectations and forecasted $300 million cash available for debt paydown in 2024. 6. Sale of aqua business to Merck Animal Health to focus on larger markets with greater earnings potential. 7. Strategic re
      Q: What is Elanco Animal Health (ELAN) Q4 2023 Earnings Call Transcript Summary?
      Comment
      Report
    • Company Profile

      Company Name
      Elanco Animal Health Inc
      Market
      NYSE
      Establishment Date
      - -
      Employees
      - -
      Office Location
      - -
      Zip Code
      - -
      Phone
      - -
      Fax
      - -
      Introduction
      Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.
    • 1D
    • 5D
    • Day
    • Week
    • Month

    Loading ...

    High
    22.63
    Open
    22.08
    Volume%
    0.85
    Low
    22.00
    Close
    22.36
    T/O Rate
    0.93%
     
     
     
     

    Most Discussed